EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Oral Nanomedicine: Challenges and Opportunities

Bo Deng, Shaomin Liu, Ying Wang, Barkat Ali, Na Kong, Tian Xie, Seyoung Koo, Jiang Ouyang, Wei Tao iD

Advanced Materials · 2024-02 · 36 (6)

DOI: 10.1002/adma.202306081 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 30.11.2023. Verfasst von Bo Deng und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Guangzhou Medical University, Guangzhou, Guangdong, 511436, China. Hauptthemen laut MEDLINE: Nanomedicine, Nanostructures. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 162 Literaturangaben. Gefördert von: American Lung Association, Cancer Discovery Award, Harvard /Brigham Health & Technology Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Compared to injection administration, oral administration is free of discomfort, wound infection, and complications and has a higher compliance rate for patients with diverse diseases. However, oral administration reduces the bioavailability of medicines, especially biologics (e.g., peptides, proteins, and antibodies), due to harsh gastrointestinal biological barriers. In this context, the development and prosperity of nanotechnology have helped improve the bioactivity and oral availability of oral medicines. On this basis, first, the biological barriers to oral administration are discussed, and then oral nanomedicine based on organic and inorganic nanomaterials and their biomedical applications in diverse diseases are reviewed. Finally, the challenges and potential opportunities in the future development of oral nanomedicine, which may provide a vital reference for the eventual clinical transformation and standardized production of oral nanomedicine, are put forward.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanomedicineNanostructuresHumansNanotechnologyPharmaceutical PreparationsAdministration, OralDrug Delivery Systems

Stichwörter der Autor:innen

bioavailabilitybiomedical applicationsnanomaterialsnanomedicineoral administration

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • School of Biomedical Engineering, Guangzhou Medical University, Guangzhou, Guangdong, 511436, China.
  • Bioinspired Engineering and Biomechanics Center, Xi'an Jiaotong University, Xi'an, 710049, China.
  • Department of Oncology of the First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China.
  • Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • College of Pharmacy, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang, 311121, China.

ORCID-Profile: Wei Tao

Förderung

  • American Lung Association
  • Cancer Discovery Award
  • Harvard /Brigham Health & Technology Innovation Fund
  • Nanotechnology Foundation
  • Farokhzad Family Distinguished Chair Foundation
  • Khoury Innovation Award
  • American Heart Association (AHA) Transformational Project Award
  • AHA's Second Century Early Faculty Independence Award

Zitieren

APA

Deng, B., Liu, S., Wang, Y., Ali, B., Kong, N., Xie, T., Koo, S., Ouyang, J., & Tao, W. (2024). Oral Nanomedicine: Challenges and Opportunities. Advanced Materials, 36(6). https://doi.org/10.1002/adma.202306081

Vancouver

Deng B, Liu S, Wang Y, Ali B, Kong N, Xie T, et al. Oral Nanomedicine: Challenges and Opportunities. Advanced Materials. 2024;36(6). doi:10.1002/adma.202306081

BibTeX
@article{Deng2024,
  author = {Deng, Bo and Liu, Shaomin and Wang, Ying and Ali, Barkat and Kong, Na and Xie, Tian and Koo, Seyoung and Ouyang, Jiang and Tao, Wei},
  title = {Oral Nanomedicine: Challenges and Opportunities},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {6},
  doi = {10.1002/adma.202306081}
}
Kostenlos starten →